{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:54Z","timestamp":1792788354994,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>X-linked inhibitor of apoptosis protein (XIAP), a member of the IAP family, is overexpressed in a variety of tumors and plays an important role in tumor progression. Increasing evidence suggests that XIAP promotes metastasis of bladder cancer but the underlying mechanism is not very clear. The RNA N6-methyladenosine (m<jats:sup>6<\/jats:sup>A) reader YTHDC1 regulates RNA splicing, nuclear transport, and mRNA stability and is a potential tumor target; however, its ubiquitin E3 ligase has not been described. In this study, screening of proteins that specifically interact with XIAP identified YTHDC1 as its degradation substrate. Ectopic overexpression of XIAP promoted degradation of YTHDC1, and knockout of XIAP upregulated YTHDC1, which inhibited metastasis of bladder cancer. Furthermore, YTHDC1 reduced the expression of matrix metalloproteinase-2 (MMP-2) by destabilizing its mRNA. These experiments revealed that XIAP promotes ubiquitination of YTHDC1, positively regulating expression of the MMP-2 and promoting metastasis of bladder cancer. Collectively, these findings demonstrate that XIAP is a critical regulator of YTHDC1 and pinpoint the XIAP\/YTHDC1\/MMP-2 axis as a promising target for the treatment of bladder cancer.<\/jats:p>","DOI":"10.1038\/s41419-025-07545-9","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T03:28:56Z","timestamp":1742959736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1"],"prefix":"10.1038","volume":"16","author":[{"given":"Ning","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-0575","authenticated-orcid":false,"given":"Hongyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenni","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2766-5016","authenticated-orcid":false,"given":"Guosong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3155-8803","authenticated-orcid":false,"given":"Chuanshu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-1528","authenticated-orcid":false,"given":"Honglei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"7545_CR1","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324:1980\u201391.","journal-title":"JAMA"},{"key":"7545_CR2","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/551S34a","volume":"551","author":"C Berdik","year":"2017","unstructured":"Berdik C. Unlocking bladder cancer. Nature. 2017;551:S34\u2013S35.","journal-title":"Nature"},{"key":"7545_CR3","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s10495-022-01734-z","volume":"27","author":"M Hanifeh","year":"2022","unstructured":"Hanifeh M, Ataei F. XIAP as a multifaceted molecule in Cellular Signaling. Apoptosis. 2022;27:441\u201353.","journal-title":"Apoptosis"},{"key":"7545_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/40901","volume":"388","author":"QL Deveraux","year":"1997","unstructured":"Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997;388:300\u20134.","journal-title":"Nature"},{"key":"7545_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/35080103","volume":"2","author":"M Holcik","year":"2001","unstructured":"Holcik M, Korneluk RG. XIAP, the guardian angel. Nat Rev Mol Cell Biol. 2001;2:550\u20136.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7545_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-016-0376-9","volume":"10","author":"C Huang","year":"2017","unstructured":"Huang C, Zeng X, Jiang G, Liao X, Liu C, Li J, et al. XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell. J Hematol Oncol. 2017;10:6.","journal-title":"J Hematol Oncol"},{"key":"7545_CR7","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1093\/emboj\/18.19.5242","volume":"18","author":"QL Deveraux","year":"1999","unstructured":"Deveraux QL, Leo E, Stennicke HR, Welsh K, Salvesen GS, Reed JC. Cleavage of human inhibitor of apoptosis protein XIAP results in fragments with distinct specificities for caspases. EMBO J. 1999;18:5242\u201351.","journal-title":"EMBO J"},{"key":"7545_CR8","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1038\/emboj.2013.133","volume":"32","author":"X Huang","year":"2013","unstructured":"Huang X, Wu Z, Mei Y, Wu M. XIAP inhibits autophagy via XIAP-Mdm2-p53 signalling. EMBO J. 2013;32:2204\u201316.","journal-title":"EMBO J"},{"key":"7545_CR9","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41388-018-0513-8","volume":"38","author":"X Huang","year":"2019","unstructured":"Huang X, Wang XN, Yuan XD, Wu WY, Lobie PE, Wu Z. XIAP facilitates breast and colon carcinoma growth via promotion of p62 depletion through ubiquitination-dependent proteasomal degradation. Oncogene. 2019;38:1448\u201360.","journal-title":"Oncogene"},{"key":"7545_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.305","volume":"8","author":"A Murali","year":"2017","unstructured":"Murali A, Shin J, Yurugi H, Krishnan A, Akutsu M, Carpy A, et al. Ubiquitin-dependent regulation of Cdc42 by XIAP. Cell Death Dis. 2017;8.e2900.","journal-title":"Cell Death Dis"},{"key":"7545_CR11","doi-asserted-by":"publisher","first-page":"e35682","DOI":"10.1371\/journal.pone.0035682","volume":"7","author":"J Liu","year":"2012","unstructured":"Liu J, Zhang D, Luo W, Yu J, Li J, Yu Y, et al. E3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activity. PLoS ONE. 2012;7:e35682.","journal-title":"PLoS ONE"},{"key":"7545_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-019-0181-8","volume":"8","author":"J Xu","year":"2019","unstructured":"Xu J, Hua X, Yang R, Jin H, Li J, Zhu J, et al. XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion. Oncogenesis. 2019;8.71.","journal-title":"Oncogenesis"},{"key":"7545_CR13","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/ijc.31223","volume":"142","author":"Y Yu","year":"2018","unstructured":"Yu Y, Jin H, Xu J, Gu J, Li X, Xie Q, et al. XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability. Int J Cancer. 2018;142:2040\u201355.","journal-title":"Int J Cancer"},{"key":"7545_CR14","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.cell.2014.08.005","volume":"158","author":"M Lee","year":"2014","unstructured":"Lee M, Kim B, Kim VN. Emerging roles of RNA modification: m(6)A and U-tail. Cell. 2014;158:980\u20137.","journal-title":"Cell"},{"key":"7545_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01340-8","volume":"20","author":"F Xu","year":"2021","unstructured":"Xu F, Li J, Ni M, Cheng J, Zhao H, Wang S, et al. FBW7 suppresses ovarian cancer development by targeting the N(6)-methyladenosine binding protein YTHDF2. Mol Cancer. 2021;20.45.","journal-title":"Mol Cancer"},{"key":"7545_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36008-y","volume":"14","author":"B Li","year":"2023","unstructured":"Li B, Xi W, Bai Y, Liu X, Zhang Y, Li L, et al. FTO-dependent m(6)A modification of Plpp3 in circSCMH1-regulated vascular repair and functional recovery following stroke. Nat Commun. 2023;14.489.","journal-title":"Nat Commun"},{"key":"7545_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41419-021-03625-8","volume":"12","author":"R Shi","year":"2021","unstructured":"Shi R, Ying S, Li Y, Zhu L, Wang X, Jin H. Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics. Cell Death Dis. 2021;12:346.","journal-title":"Cell Death Dis"},{"key":"7545_CR18","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1083\/jcb.150.5.949","volume":"150","author":"O Nayler","year":"2000","unstructured":"Nayler O, Hartmann AM, Stamm S. The ER repeat protein YT521-B localizes to a novel subnuclear compartment. J Cell Biol. 2000;150:949\u201362.","journal-title":"J Cell Biol"},{"key":"7545_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0169-328X(97)00262-3","volume":"53","author":"Y Imai","year":"1998","unstructured":"Imai Y, Matsuo N, Ogawa S, Tohyama M, Takagi T. Cloning of a gene, YT521, for a novel RNA splicing-related protein induced by hypoxia\/reoxygenation. Brain Res Mol Brain Res. 1998;53:33\u201340.","journal-title":"Brain Res Mol Brain Res"},{"key":"7545_CR20","doi-asserted-by":"publisher","first-page":"11619","DOI":"10.1093\/nar\/gkac1027","volume":"50","author":"L Chen","year":"2022","unstructured":"Chen L, Zhang C, Ma W, Huang J, Zhao Y, Liu H. METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability. Nucleic Acids Res. 2022;50:11619\u201334.","journal-title":"Nucleic Acids Res"},{"key":"7545_CR21","doi-asserted-by":"crossref","unstructured":"Roundtree IA, Luo GZ, Zhang Z, Wang X, Zhou T, Cui Y, et al. YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs. Elife. 2017;6:31311.","DOI":"10.7554\/eLife.31311"},{"key":"7545_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","volume":"61","author":"W Xiao","year":"2016","unstructured":"Xiao W, Adhikari S, Dahal U, Chen YS, Hao YJ, Sun BF, et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing. Mol Cell. 2016;61:507\u201319.","journal-title":"Mol Cell"},{"key":"7545_CR23","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.7150\/thno.71872","volume":"12","author":"B Tan","year":"2022","unstructured":"Tan B, Zhou K, Liu W, Prince E, Qing Y, Li Y, et al. RNA N(6) -methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer. Theranostics. 2022;12:5727\u201343.","journal-title":"Theranostics"},{"key":"7545_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-022-00905-3","volume":"7","author":"S Li","year":"2022","unstructured":"Li S, Qi Y, Yu J, Hao Y, He B, Zhang M, et al. Nuclear Aurora kinase A switches m(6)A reader YTHDC1 to enhance an oncogenic RNA splicing of tumor suppressor RBM4. Signal Transduct Target Ther. 2022;7:97.","journal-title":"Signal Transduct Target Ther"},{"key":"7545_CR25","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1038\/s12276-023-00997-z","volume":"55","author":"B Yan","year":"2023","unstructured":"Yan B, Li X, Peng M, Zuo Y, Wang Y, Liu P, et al. The YTHDC1\/GLUT3\/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression. Exp Mol Med. 2023;55:1145\u201358.","journal-title":"Exp Mol Med"},{"key":"7545_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03186-2","volume":"11","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Wang Q, Zhao X, Shao L, Liu G, Zheng X, et al. YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA. Cell Death Dis. 2020;11.977.","journal-title":"Cell Death Dis"},{"key":"7545_CR27","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27:1115\u201327.","journal-title":"Cell Res"},{"key":"7545_CR28","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.molcel.2017.09.021","volume":"68","author":"MN Wojtas","year":"2017","unstructured":"Wojtas MN, Pandey RR, Mendel M, Homolka D, Sachidanandam R, Pillai RS. Regulation of m(6)A Transcripts by the 3\u2019->5\u2019 RNA helicase YTHDC2 is essential for a successful meiotic program in the mammalian germline. Mol Cell. 2017;68:374\u201387.e312.","journal-title":"Mol Cell"},{"key":"7545_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01705-7","volume":"21","author":"J Wang","year":"2022","unstructured":"Wang J, Tan L, Yu X, Cao X, Jia B, Chen R, et al. lncRNA ZNRD1-AS1 promotes malignant lung cell proliferation, migration, and angiogenesis via the miR-942\/TNS1 axis and is positively regulated by the m(6)A reader YTHDC2. Mol Cancer. 2022;21.229.","journal-title":"Mol Cancer"},{"key":"7545_CR30","doi-asserted-by":"publisher","first-page":"216420","DOI":"10.1016\/j.canlet.2023.216420","volume":"576","author":"L Chen","year":"2023","unstructured":"Chen L, Sun K, Qin W, Huang B, Wu C, Chen J, et al. LIMK1 m(6)A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation. Cancer Lett. 2023;576:216420.","journal-title":"Cancer Lett"},{"key":"7545_CR31","doi-asserted-by":"publisher","first-page":"101308","DOI":"10.1016\/j.tranon.2021.101308","volume":"16","author":"W Yuan","year":"2022","unstructured":"Yuan W, Chen S, Li B, Han X, Meng B, Zou Y, et al. The N6-methyladenosine reader protein YTHDC2 promotes gastric cancer progression via enhancing YAP mRNA translation. Transl Oncol. 2022;16:101308.","journal-title":"Transl Oncol"},{"key":"7545_CR32","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1126\/science.288.5467.874","volume":"288","author":"Y Yang","year":"2000","unstructured":"Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 2000;288:874\u20137.","journal-title":"Science"},{"key":"7545_CR33","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/ncb1789","volume":"10","author":"M Gyrd-Hansen","year":"2008","unstructured":"Gyrd-Hansen M, Darding M, Miasari M, Santoro MM, Zender L, Xue W, et al. IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-kappaB as well as cell survival and oncogenesis. Nat Cell Biol. 2008;10:1309\u201317.","journal-title":"Nat Cell Biol"},{"key":"7545_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/cdd.2009.81","volume":"17","author":"S Galban","year":"2010","unstructured":"Galban S, Duckett CS. XIAP as a ubiquitin ligase in cellular signaling. Cell Death Differ. 2010;17:54\u201360.","journal-title":"Cell Death Differ"},{"key":"7545_CR35","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"LGN de Almeida","year":"2022","unstructured":"de Almeida LGN, Thode H, Eslambolchi Y, Chopra S, Young D, Gill S, et al. Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology. Pharmacol Rev. 2022;74:712\u201368.","journal-title":"Pharmacol Rev"},{"key":"7545_CR36","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1002\/1878-0261.12132","volume":"11","author":"H Huang","year":"2017","unstructured":"Huang H, Jin H, Zhao H, Wang J, Li X, Yan H, et al. RhoGDIbeta promotes Sp1\/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation. Mol Oncol. 2017;11:1579\u201394.","journal-title":"Mol Oncol"},{"key":"7545_CR37","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1038\/s41388-019-1120-z","volume":"39","author":"R Yang","year":"2020","unstructured":"Yang R, Xu J, Hua X, Tian Z, Xie Q, Li J, et al. Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer\/miR-16\/JNK2\/MMP-2 axis. Oncogene. 2020;39:1983\u201396.","journal-title":"Oncogene"},{"key":"7545_CR38","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1016\/j.celrep.2017.11.092","volume":"21","author":"H Shima","year":"2017","unstructured":"Shima H, Matsumoto M, Ishigami Y, Ebina M, Muto A, Sato Y, et al. S-adenosylmethionine synthesis is regulated by selective N(6)-adenosine methylation and mRNA degradation involving METTL16 and YTHDC1. Cell Rep. 2017;21:3354\u201363.","journal-title":"Cell Rep."},{"key":"7545_CR39","doi-asserted-by":"crossref","unstructured":"Tu H, Costa M. XIAP\u2019s profile in human cancer. Biomolecules. 2020;10:1493.","DOI":"10.3390\/biom10111493"},{"key":"7545_CR40","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s10495-017-1375-1","volume":"22","author":"R Rathore","year":"2017","unstructured":"Rathore R, McCallum JE, Varghese E, Florea AM, Busselberg D. Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs). Apoptosis. 2017;22:898\u2013919.","journal-title":"Apoptosis"},{"key":"7545_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ccr.2009.11.021","volume":"17","author":"S Mehrotra","year":"2010","unstructured":"Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, Altieri DC. IAP regulation of metastasis. Cancer Cell. 2010;17:53\u201364.","journal-title":"Cancer Cell"},{"key":"7545_CR42","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202153608","volume":"23","author":"M Daoud","year":"2022","unstructured":"Daoud M, Broxtermann PN, Schorn F, Werthenbach JP, Seeger JM, Schiffmann LM, et al. XIAP promotes melanoma growth by inducing tumour neutrophil infiltration. EMBO Rep. 2022;23.e53608.","journal-title":"EMBO Rep."},{"key":"7545_CR43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, Rak J, De Braekeleer E, Tsagkogeorga G, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593:597\u2013601.","journal-title":"Nature"},{"key":"7545_CR44","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41467-020-20379-7","volume":"12","author":"R Fang","year":"2021","unstructured":"Fang R, Chen X, Zhang S, Shi H, Ye Y, Shi H, et al. EGFR\/SRC\/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma. Nat Commun. 2021;12:177.","journal-title":"Nat Commun"},{"key":"7545_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Liu Z, Wang T, She Y, Wu K, Gu S, Li L, et al. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 2021;20.105.","journal-title":"Mol Cancer"},{"key":"7545_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1036-9","volume":"18","author":"J Han","year":"2019","unstructured":"Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, et al. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner. Mol Cancer. 2019;18.110.","journal-title":"Mol Cancer"},{"key":"7545_CR47","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-21-1323","volume":"82","author":"Z Ni","year":"2022","unstructured":"Ni Z, Sun P, Zheng J, Wu M, Yang C, Cheng M, et al. JNK signaling promotes bladder cancer immune escape by regulating METTL3-mediated m6A modification of PD-L1 mRNA. Cancer Res. 2022;82:1789\u2013802.","journal-title":"Cancer Res"},{"key":"7545_CR48","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1002\/1878-0261.13181","volume":"16","author":"C Guimaraes-Teixeira","year":"2022","unstructured":"Guimaraes-Teixeira C, Lobo J, Miranda-Goncalves V, Barros-Silva D, Martins-Lima C, Monteiro-Reis S, et al. Downregulation of m(6) A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness. Mol Oncol. 2022;16:1841\u201356.","journal-title":"Mol Oncol"},{"key":"7545_CR49","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-22-2485","volume":"83","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li Y, Zhou L, Zhou H, Ye L, Ou T, et al. The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response. Cancer Res. 2023;83:1834\u201350.","journal-title":"Cancer Res"},{"key":"7545_CR50","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41586-021-03313-9","volume":"591","author":"J Liu","year":"2021","unstructured":"Liu J, Gao M, He J, Wu K, Lin S, Jin L, et al. The RNA m(6)A reader YTHDC1 silences retrotransposons and guards ES cell identity. Nature. 2021;591:322\u20136.","journal-title":"Nature"},{"key":"7545_CR51","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.1182\/blood.2021011707","volume":"138","author":"Y Sheng","year":"2021","unstructured":"Sheng Y, Wei J, Yu F, Xu H, Yu C, Wu Q, et al. A critical role of nuclear m6A reader YTHDC1 in leukemogenesis by regulating MCM complex-mediated DNA replication. Blood. 2021;138:2838\u201352.","journal-title":"Blood"},{"key":"7545_CR52","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nrm2125","volume":"8","author":"A Page-McCaw","year":"2007","unstructured":"Page-McCaw A, Ewald AJ, Werb Z. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol. 2007;8:221\u201333.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7545_CR53","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:161\u201374.","journal-title":"Nat Rev Cancer"},{"key":"7545_CR54","doi-asserted-by":"crossref","unstructured":"Xie Q, Hua X, Huang C, Liao X, Tian Z, Xu J, et al. SOX2 promotes invasion in human bladder cancers through MMP2 upregulation and FOXO1 downregulation. Int J Mol Sci. 2022;23:12532.","DOI":"10.3390\/ijms232012532"},{"key":"7545_CR55","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1080\/15548627.2020.1733262","volume":"17","author":"H Jin","year":"2021","unstructured":"Jin H, Ma J, Xu J, Li H, Chang Y, Zang N, et al. Oncogenic role of MIR516A in human bladder cancer was mediated by its attenuating PHLPP2 expression and BECN1-dependent autophagy. Autophagy. 2021;17:840\u201354.","journal-title":"Autophagy"},{"key":"7545_CR56","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1038\/s41388-021-02033-8","volume":"40","author":"S Ren","year":"2021","unstructured":"Ren S, Zhang N, Shen L, Lu Y, Chang Y, Lin Z, et al. Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA\/RhoC mRNA and impairing bladder cancer invasion. Oncogene. 2021;40:6579\u201389.","journal-title":"Oncogene"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07545-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07545-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07545-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T05:34:02Z","timestamp":1743312842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07545-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7545"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07545-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"6 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of Wenzhou Medical University. All the animal experiments performed in the present study were approved by the regulation of the experimental animal ethics committee of Wenzhou Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"205"}}